Article
Extreme phenotypic variability of thyroid dysgenesis in six new cases of congenital hypothyroidism due to PAX8 gene loss-of-function mutations
Registro en:
RAMOS, H. E. et al. Extreme phenotypic variability of thyroid dysgenesis in six new cases of congenital hypothyroidism due to PAX8 gene loss-of-function mutations. European Journal of Endocrinology, v. 171, p. 499–507, 2014.
0804-4643
10.1530/EJE-13-1006
Autor
Ramos, Helton Estrela
Carré, A
Chevrier, L
Szinnai, G
Tron, E
Cerqueira, Taíse Lima de Oliveira
Léger, J
Cabrol, S
Puel, O
Queinnec, C
De Roux, N
Guillot, L
Castanet, M
Polak, M
Resumen
Electricité de France (RB 200605), the European Society for Paediatric Endocrinology (ESPE)
Research Unit (M Polak), Fondation Grace de Monaco and PHRC 2011 Hypotygen sponsored by the French Ministry, SFE (Société française d’endocrinologie) MercK Serono grant (M Castanet), Fapesb (Fundação
de Amparo à Pesquisa no Estado da Bahia), and CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico). Within the last two decades, heterozygous loss-of-function PAX8 mutations have been reported in patients with a wide degree of thyroid gland dysfunction and growth despite the presence of identical mutations. Objectives: To search for PAX8 mutations in a cohort of patients with congenital hypothyroidism (CH) and various types of
thyroid gland defects.
Design: A cross-sectional study was conducted in a cohort of patients.
Setting: The French neonatal screening program was used for recruiting patients.
Patients: A total of 118 patients with CH, including 45 with familial and 73 with sporadic diseases, were included in this study.
The thyroid gland was normal in 23 patients had hypoplasia, 25 had hemithyroid agenesis, 21 had athyreosis, and 21 had
ectopy.
Results: We found four different PAX8 mutations (p.R31C, p.R31H, p.R108X, and p.I47T) in ten patients (six patients with CH
and four family members), two with sporadic and eight with familial diseases. Imaging studies performed in the index cases
showed ectopic thyroid gland (nZ2), hypoplasia (nZ2), eutopic lobar asymmetry (nZ1), and eutopic gland compatible with
dyshormonogenesis (nZ1). The previously reported p.R31C and the novel p.I47T PAX8 mutations are devoid of activity.
Conclusion: Four different PAX8 mutations were detected in six index patients with CH (ten total subjects). The p.R31C,
p.R31H, and p.R108X mutations have been reported. The novel p.I47T PAX8 mutation presented loss of function leading to
CH. Thyroid ectopy was observed in two cases of PAX8 (p.R31H) mutation, a finding that has not been reported previously.
We observed a high inter-individual and intra-familial variability of the phenotype in PAX8 mutations, underlining that
population genetic studies for CH should include patients with various clinical presentations